English
Langerhans cells (LCs) reside in the skin epidermis and mucosal epithelia such as vagina, foreskin and are the first immune cells to encounter HIV-1 upon sexual transmission. LCs express the C-type lectin receptor Langerin which prevents infection of LCs and subsequent HIV-1 transmission. Langerin captures HIV-1 into Birbeck granules where the virus is thought to be degraded. Although this Langerin-specific internalization pathway is central to the ability of LCs to degrade HIV-1, the function of Birbeck granules and the molecular mechanisms involved in HIV-1 degradation are largely unknown. Autophagy can function as an antiviral mechanism by targeting viral components or virions for lysosomal degradation. Strikingly, my preliminary data demonstrate that HIV-1 induces autophagy in LCs and that boosting autophagy-mediated lysis enhances HIV-1 degradation in LCs. Moreover, my findings that Birbeck granules are caveolar vesicles limiting HIV-1 infection in LCs further suggests that caveolar-mediated uptake is linked to viral degradation. Based on my data, I hypothesize that the autophagy pathway has an important role in the caveolin-dependent degradation of HIV-1 and that the autophagy pathway is essential to mount an effective antiviral immune response against HIV and other viruses in LCs. I will use highly purified LCs to define the signalling pathways required to induce autophagy and to identify the potency of autophagy in preventing HIV-1 infection in LCs. An ex vivo human genital tissue infection model will be used to investigate the role of autophagy in HIV-1 transmission during co-infections with other sexually-transmitted diseases. Our exciting preliminary data, expertise in signalling pathways and the combination of immunological and virological techniques will be fundamental for the success of this project. Ultimately, this study will provide new insights into the autophagy-mediated pathways, the molecular action of autophagosomal molecules and will promote the development of novel microbicides to combat viral infections.
